BIOL insider trading

BIOLASE, INC: insider trade history from SEC Form 4 filings.

Total Form 4 trades
183
Last 90 days
0
Buys / sells
57% / 13%
Market cap
—

BIOL insider activity at a glance

FilingIQ tracks 183 insider transactions for BIOL in filings since Aug 31, 2015. The most recent transaction is dated Dec 7, 2022.

Across the full history, 105 open-market purchases and 24 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Latest BIOL Form 4 filings

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Frequently asked

How many insider trades does FilingIQ track for BIOL?
FilingIQ tracks 183 Form 4 insider transactions for BIOL (BIOLASE, INC), covering filings from Aug 31, 2015 onwards. 0 of those are dated within the last 90 days.
Are BIOL insiders net buyers or net sellers?
Across the full Form 4 history for BIOL, 105 transactions (57%) were open-market purchases and 24 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BIOL insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

Methodology & sources

Every BIOL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.